FAM
DNLI icon

Fred Alger Management’s Denali Therapeutics DNLI Stock Holding History

Fred Alger Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-91,807
Closed -$1.87M – 434
2024
Q4 		$1.87M Sell
91,807
-29,509
-24% -$755K 0.01% 335
2024
Q3 		$3.53M Buy
121,316
+94,302
+349% +$2.34M 0.02% 280
2024
Q2 		$627K Buy
+27,014
New +$519K ﹤0.01% 369
2022
Q3 		– Sell
-8,983
Closed -$264K – 528
2022
Q2 		$264K Buy
+8,983
New +$235K ﹤0.01% 421
2021
Q2 		– Sell
-16,634
Closed -$950K – 517
2021
Q1 		$950K Sell
16,634
-244
-1% -$16.3K ﹤0.01% 390
2020
Q4 		$1.41M Buy
+16,878
New +$1.02M ﹤0.01% 348

Other funds holding DNLI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return